what does medicamen biotech do

Medicamen Biotech Limited is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations and oncology formulations.

what products does medicamen biotech make

Medicamen Biotech Limited produces generic finished dosage formulations and oncology formulations, including pharmaceutical products for various therapeutic areas.

what sector is medicamen biotech in

Medicamen Biotech Limited operates in the pharmaceutical sector, focusing on the development and manufacturing of generic and oncology drugs.

when was medicamen biotech founded

Medicamen Biotech Limited was founded in December 1993.

who owns medicamen biotech

Medicamen Biotech Limited is owned by Shivalik Rasayan Ltd., which is its parent company.

Medicamen Biotech Limited (MEDICAMEQ) Share Price Today — ₹231.2

Medicamen Biotech Limited (MEDICAMEQ) live stock price is ₹231.2. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Medicamen Biotech Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Medicamen Biotech Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

MEDICAMEQ

BSE

Medicamen Biotech Limited

Healthcare· Pharmaceuticals & Biotechnology· INE646B01010· Scrip: 531146

EN हिन्दी ગુજરાતી मराठी

₹231.20

▲ 7.50 (+0.00%)

2026-06-10

BSE

₹231.20

▲ 7.50

+0.00%

233 trading days · 1Y period

TODAY (BSE)

Open241.55

High243.75

Low227.95

Prev Close238.70

Volume2,129

Value₹0.0Cr

L: 227.95H: 243.75

Info

Face Value₹10

Listed2021-10-27

ISININE646B01010

SeriesB

BSE Scrip531146

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+0.89%

PAT+223.27%

EPS+223.94%

Profitability

EBITDA Margin17.3%

Net Margin6.5%

TTM EBITDA M.14.5%

TTM Net M.3.7%

Dividend

Yield—

Latest DPS₹1

Payout Ratio43.5%

Growth+0.00%

TTM Revenue

₹180 Cr

TTM EBITDA

₹26 Cr

TTM PAT

₹7 Cr

TTM EPS

₹5.25

Rev/Share

₹132.9

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	45 Cr	41 Cr	8 Cr	4 Cr	3 Cr	₹2.30
2024-09-30	45 Cr	43 Cr	7 Cr	2 Cr	1 Cr	₹0.71
2024-06-30	43 Cr	42 Cr	5 Cr	2 Cr	1 Cr	₹0.63
2024-03-31	47 Cr	45 Cr	7 Cr	3 Cr	2 Cr	₹1.61
2023-12-31	47 Cr	44 Cr	7 Cr	3 Cr	2 Cr	₹1.60
2023-09-30	44 Cr	42 Cr	6 Cr	2 Cr	1 Cr	₹1.17
2023-06-30	42 Cr	38 Cr	8 Cr	5 Cr	4 Cr	₹3.12
2023-03-31	39 Cr	35 Cr	7 Cr	4 Cr	4 Cr	₹3.03

Shareholding Pattern

CURRENT — 2026-03-31

Promoter40.5%

FII0.1%

Public59.5%

Govt0.1%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-09-19	Dividend	Dividend - Re 1 Per Share
2024-09-19	Dividend	Annual General Meeting/Dividend - Re 1 Per Share
2023-09-20	Dividend	Annual General Meeting/Dividend - Re 1 Per Share
2022-09-19	Dividend	Annual General Meeting/Dividend - Re 1 Per Share

Earnings Transcripts

Medicamen Biotech Limited has informed the Exchange about Investor Presentation

4 Dec 2021NSE16K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	241.80	243.80	227.90	230.10	44,041
2026-06-03	271.35	275.90	264.00	265.70	12,157
2026-05-27	270.50	300.80	257.60	284.60	69,893
2026-05-26	272.95	278.95	268.35	272.30	5,687
2026-05-25	269.55	277.50	265.40	270.65	11,753
2026-05-22	265.00	273.40	264.15	269.55	7,156
2026-05-21	277.00	281.60	264.15	266.85	13,292
2026-05-20	274.70	278.70	266.10	274.45	13,339
2026-05-19	271.90	275.55	268.00	269.20	5,263
2026-05-18	274.90	274.90	266.00	268.90	8,437
2026-05-15	275.00	278.00	268.00	277.45	14,103
2026-05-14	278.00	294.05	268.10	271.80	37,047
2026-05-13	279.95	285.45	274.00	278.05	24,429
2026-05-12	290.00	290.00	273.90	277.80	15,112
2026-05-11	294.30	294.35	280.10	291.60	24,681
2026-05-08	294.90	299.70	283.20	294.30	11,812
2026-05-07	285.30	299.00	285.30	294.25	18,178
2026-05-06	285.90	296.00	278.40	290.55	41,368
2026-05-05	262.50	284.60	259.95	281.10	67,904
2026-05-04	258.65	262.00	253.55	258.10	19,312
2026-04-30	250.00	257.18	247.00	254.53	15,419
2026-04-29	248.21	256.75	248.20	249.28	16,739
2026-04-28	254.40	257.72	245.00	248.24	18,787
2026-04-27	253.80	263.70	245.00	252.28	50,677
2026-04-24	262.00	262.50	253.63	257.66	20,491
2026-04-23	268.41	268.45	257.30	259.48	24,044
2026-04-22	264.85	269.90	260.20	268.41	16,489
2026-04-21	266.96	273.00	260.00	261.47	20,044
2026-04-20	259.98	273.00	258.58	268.30	43,765
2026-04-17	250.00	260.55	249.99	258.22	32,887

Frequently Asked Questions

About

Medicamen Biotech Limited is an Indian pharmaceutical company engaged in the manufacturing and marketing of quality medicines, with a focus on providing affordable healthcare solutions. The company operates in both domestic and international markets, offering a range of pharmaceutical formulations and has established itself as one of India's leading private sector enterprises since its inception in 1993.

BOARD OF DIRECTORS

Harish Pande

Independent Director

Nehru Place